C3, C5a and anti-acetylcholine receptor antibody as severity biomarkers in myasthenia gravis

BACKGROUND: Although the pathogenesis of myasthenia gravis (MG) is well known, prognostic markers are not yet available. We assessed the utility of anti-acetylcholine receptor (AChR) antibody (AChR-ab) titer and concentration of C3, C4, and C5a as potential severity biomarkers in MG. METHODS: Levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Aguirre, Florencia, Manin, Analisa, Fernandez, Victoria C., Justo, Mariano E., Leoni, Juliana, Paz, Mariela L., Villa, Andres M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Autoimmune Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418469/
https://www.ncbi.nlm.nih.gov/pubmed/32843900
http://dx.doi.org/10.1177/1756286420935697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418469/
https://www.ncbi.nlm.nih.gov/pubmed/32843900
http://dx.doi.org/10.1177/1756286420935697

Ejemplares similares